Enabling you to identify and mitigate the intrinsic risk in your operations, supply chains and business processes.
Evaluating how your products and services meet and exceed quality, safety, sustainability and performance standards.
Validating the specifications, value and safety of your raw materials, products and assets.
GLP and GCP bioanalytical services supporting all phases of drug development and non-GLP rapid discovery phase bioanalysis via state of the art facilities
Intertek has over 20 years experience in conducting regulated bioanalytical studies supporting the development of pharmaceuticals, biopharmaceuticals, vaccines and biosimilars. Expert bioanalysis support for both small molecule drugs and biologics is provided through our global network of state-of-the-art, GLP-compliant laboratories located in California, US (San Diego) and in the UK (Manchester).
Capabilities include proprietary method development, validation, method transfer, high throughput sample analysis and pharmacokinetic and toxicokinetic support, combined with automated data capture and reporting system. Clinical sample management services are provided for collection and shipment of samples from clinical study sites.
Recognizing the critical role bioanalysis plays in drug development, our mission is to consistently deliver accurate and reliable data that is subject to rigorous scientific and regulatory review, ensuring the success of your discovery, preclinical and clinical programs.
Bioanalytical Services for Preclinical and Clinical Studies:
Small Molecule Bioanalytical Services:
Large Molecule Bioanalytical Services:
Intertek is a world leading provider of immunochemistry and biomarker services for bioanalytical studies supporting the preclinical and clinical development of protein based therapeutics and other biologic medicines.
Need help or have a question?